reports
Hamilton Thorne Announces Shareholder Approval of Going Private Transa...
Hamilton Thorne Announces Shareholder Approval of Going Private Transaction BEVERLY, Mass. and TORONTO, Sept. 17, 2024 (GLOBE NEWSWIRE) -- Hamilton Thorne Ltd (TSX: HTL) (“Hamilton Thorne” or the “Company”), a leading provider of precision instruments, consumables, software, and services to the Assisted Reproductive Technologies (“ART”), research, and the cell biology fields, today announced that the shareholders of the Company (the "Shareholders"), at a special meeting of Shareholders held earlier today (the "Meeting"), approved a statutory plan of arrangement (the "Transaction") under t...
Hamilton Thorne Announces Mailing of Meeting Materials and Receipt of ...
Hamilton Thorne Announces Mailing of Meeting Materials and Receipt of Interim Order in Respect of Going Private Transaction BEVERLY, Mass. and TORONTO, Aug. 26, 2024 (GLOBE NEWSWIRE) -- Hamilton Thorne Ltd (TSX: HTL) (“Hamilton Thorne” or the “Company”), a leading provider of precision instruments, consumables, software, and services to the Assisted Reproductive Technologies (“ART”), research, and the cell biology space, today announced the mailing of its notice of meeting, management information circular (the "Circular"), form of proxy and letter of transmittal (collectively, the "Meetin...
Hamilton Thorne Reports Revenue for the Quarter and Six Months Ended J...
Hamilton Thorne Reports Revenue for the Quarter and Six Months Ended June 30, 2024, and Confirms Annual Guidance Revenue of $19.1 million and Adjusted EBITDA of $3.2 million for the quarter BEVERLY, Mass. and TORONTO, Aug. 14, 2024 (GLOBE NEWSWIRE) -- Hamilton Thorne Ltd. (TSX: HTL), a leading provider of precision instruments, laboratory equipment, consumables, software, and services to the Assisted Reproductive Technologies (ART), research, and cell biology markets, today reported audited financial results for the quarter and six months ended June 30, 2024. Financial Highlights Sal...
Hamilton Thorne to Release Q2 2024 Financial Results on August 14, 202...
Hamilton Thorne to Release Q2 2024 Financial Results on August 14, 2024 BEVERLY, Mass. and TORONTO, Aug. 07, 2024 (GLOBE NEWSWIRE) -- Hamilton Thorne Ltd. (TSX: HTL), a leading provider of precision instruments, laboratory equipment, consumables, software and services to the Assisted Reproductive Technologies (ART), research, and cell biology markets, today announced that it will release its financial results for the three and six months ended June 30, 2024 before market open on Wednesday, August 14, 2024. The press release, with accompanying financial information, will be posted on the C...
Hamilton Thorne Announces Agreement to be Acquired by Astorg for CAD$2...
Hamilton Thorne Announces Agreement to be Acquired by Astorg for CAD$2.25 Per Share in Cash Purchase price of CAD$2.25 per Hamilton Thorne share represents enterprise value of approximately CAD$388 million (US$282 million).Represents a premium of approximately 54% to the closing price on the Toronto Stock Exchange (“TSX”) of Hamilton Thorne shares on July 19, 2024, the last trading day prior to the announcement of the transaction, and approximately 62% to the 90-day VWAP as of the same date1.The Board of Directors of Hamilton Thorne (with interested directors abstaining) unanimously determi...
Hamilton Thorne Announces Voting Results of 2024 Annual Meeting
Hamilton Thorne Announces Voting Results of 2024 Annual Meeting BEVERLY, Mass. and TORONTO, June 11, 2024 (GLOBE NEWSWIRE) -- Hamilton Thorne Ltd. (TSX: HTL) ("Hamilton Thorne" or the "Company"), a leading provider of precision instruments, consumables, software, and services to the Assisted Reproductive Technologies ("ART") research and cell biology markets, today announced the voting results from its Annual General and Special Meeting of Shareholders held on Tuesday June 11, 2024 (the “Meeting”). A total of 99,394,475 common shares were voted at the Meeting, representing 64.65% of the v...
Hamilton Thorne Reports Record Revenue and EBITDA for the Quarter Ende...
Hamilton Thorne Reports Record Revenue and EBITDA for the Quarter Ended March 31, 2024, and Confirms Annual Guidance Revenue of $19.4 million and Adjusted EBITDA of $3.5 for the quarter BEVERLY, Mass. and TORONTO, May 14, 2024 (GLOBE NEWSWIRE) -- Hamilton Thorne Ltd. (TSX: HTL), a leading provider of precision instruments, laboratory equipment, consumables, software, and services to the Assisted Reproductive Technologies (ART), research, and cell biology markets, today reported audited financial results for the quarter ended March 31, 2024. Financial Highlights 1st quarter sales i...
Hamilton Thorne to Announce Q1 2024 Financial Results and Hold Confere...
Hamilton Thorne to Announce Q1 2024 Financial Results and Hold Conference Call on May 14, 2024 BEVERLY, Mass. and TORONTO, May 06, 2024 (GLOBE NEWSWIRE) -- Hamilton Thorne Ltd. (TSX: HTL), a leading provider of precision instruments, laboratory equipment, consumables, software and services to the Assisted Reproductive Technologies (ART), research, and cell biology markets, today announced that it will release its financial results for the three months ended March 31, 2024 before market open on Tuesday, May 14, 2024. The press release, with accompanying financial information, will be poste...
Hamilton Thorne Reports Record Revenue and EBITDA for the Quarter and ...
Hamilton Thorne Reports Record Revenue and EBITDA for the Quarter and Year Ended December 31, 2023 Revenue of $67.2 million for the year and $18.4 million for the 4th quarter; Adj. EBITDA of $11.5 million for the year and $3.7 million for the quarter BEVERLY, Mass. and TORONTO, March 27, 2024 (GLOBE NEWSWIRE) -- Hamilton Thorne Ltd. (TSX: HTL), a leading provider of precision instruments, laboratory equipment, consumables, software and services to the Assisted Reproductive Technologies (ART), research, and cell biology markets, today reported audited financial results for the fourth qua...
Hamilton Thorne to Announce Q4 and Full Year 2023 Financial Results an...
Hamilton Thorne to Announce Q4 and Full Year 2023 Financial Results and Hold Conference Call on March 27, 2024 BEVERLY, Mass. and TORONTO, March 21, 2024 (GLOBE NEWSWIRE) -- Hamilton Thorne Ltd. (TSX: HTL), a leading provider of precision instruments, laboratory equipment, consumables, software and services to the Assisted Reproductive Technologies (ART), research, and cell biology markets, today announced that it will release its financial results for the three and twelve months ended December 31, 2023 before market open on Wednesday, March 27, 2024. The press release, with accompanying ...
Hamilton Thorne Appoints Dr. Ekaterina (Kate) Torchilin as President ...
Hamilton Thorne Appoints Dr. Ekaterina (Kate) Torchilin as President and CEO David Wolf to move to Executive Chairman BEVERLY, Mass. and TORONTO, Dec. 21, 2023 (GLOBE NEWSWIRE) -- Hamilton Thorne Ltd. (TSX: HTL), a leading provider of precision instruments, consumables, software and services to the Assisted Reproductive Technologies (ART), research, and cell biology markets, today announced the appointment, of Dr. Ekaterina (Kate) Torchilin as its new President and Chief Executive Officer, effective January 15, 2024. Dr. Torchilin is succeeding David Wolf, who is retiring as Presi...
Hamilton Thorne Reports Revenue for the Quarter and Nine Months Ended ...
Hamilton Thorne Reports Revenue for the Quarter and Nine Months Ended September 30, 2023 Revenue up 16% to $15.7 million and Adjusted EBITDA up 3% to $2.2 million for the quarter BEVERLY, Mass. and TORONTO, Nov. 13, 2023 (GLOBE NEWSWIRE) -- Hamilton Thorne Ltd. (TSX: HTL), a leading provider of precision instruments, consumables, software and services to the Assisted Reproductive Technologies (ART), research, and cell biology markets, today reported audited financial results for the quarter and nine months ended September 30, 2023. Financial Highlights Sales increased 16% year over ye...
Hamilton Thorne to Announce Q3 2023 Financial Results and Hold Confere...
Hamilton Thorne to Announce Q3 2023 Financial Results and Hold Conference Call on November 13, 2023 BEVERLY, Mass. and TORONTO, Nov. 07, 2023 (GLOBE NEWSWIRE) -- Hamilton Thorne Ltd. (TSX: HTL), a leading provider of precision instruments, consumables, software and services to the Assisted Reproductive Technologies (ART), research, and cell biology markets, today announced that it will release its financial results for the three and nine months ended September 30, 2023 before market open on Monday, November 13, 2023. The press release, with accompanying financial information, will be post...
Hamilton Thorne Graduating to Toronto Stock Exchange Main Board
Hamilton Thorne Graduating to Toronto Stock Exchange Main Board Trading on the TSX to commence September 7, 2023 BEVERLY, Mass. and TORONTO, Sept. 06, 2023 (GLOBE NEWSWIRE) -- Hamilton Thorne Ltd. (TSX-V: HTL), a leading provider of precision instruments, consumables, software and services to the Assisted Reproductive Technologies (ART), research, and cell biology markets, today announced its graduation from the TSX Venture Exchange to the Toronto Stock Exchange (TSX) main board, effective September 7, 2023. Hamilton Thorne’s symbol (HTL) will remain unchanged. David Wolf, Pres...
Hamilton Thorne Reports Revenue For The Quarter And Six Months Ended J...
Hamilton Thorne Reports Revenue For The Quarter And Six Months Ended June 30, 2023 Revenue of $16.4 million and Adjusted EBITDA of $2.8 million for the quarter BEVERLY, Mass. and TORONTO, Aug. 17, 2023 (GLOBE NEWSWIRE) -- Hamilton Thorne Ltd. (TSX-V: HTL), a leading provider of precision instruments, consumables, software and services to the Assisted Reproductive Technologies (ART), research, and cell biology markets, today reported audited financial results for the quarter and six months ended June 30, 2023. Financial Highlights Sales increased 15% year over year to $16.4 million for...
Hamilton Thorne to Announce Q2 2023 Financial Results and Hold Confere...
Hamilton Thorne to Announce Q2 2023 Financial Results and Hold Conference Call on August 17, 2023 BEVERLY, Mass. and TORONTO, Aug. 10, 2023 (GLOBE NEWSWIRE) -- Hamilton Thorne Ltd. (TSX-V: HTL), a leading provider of precision instruments, consumables, software and services to the Assisted Reproductive Technologies (ART), research, and cell biology markets, today announced that it will release its financial results for the three and six months ended June 30, 2023 before market open on Thursday, August 17, 2023. The press release, with accompanying financial information, will be posted on ...
Hamilton Thorne Reports Record Revenue for the Quarter Ended March 31,...
Hamilton Thorne Reports Record Revenue for the Quarter Ended March 31, 2023 Revenue of $16.7 million and Adjusted EBITDA of $2.8 for the quarter BEVERLY, Mass. and TORONTO, May 15, 2023 (GLOBE NEWSWIRE) -- Hamilton Thorne Ltd. (TSX-V: HTL), a leading provider of precision instruments, consumables, software and services to the Assisted Reproductive Technologies (ART), research, and cell biology markets, today reported financial results for the quarter ended March 31, 2023. Financial Highlights 1st quarter sales increased 19% to $16.7 million; sales for the quarter increased...
Hamilton Thorne to Announce Q1 2023 Financial Results and Hold Confere...
Hamilton Thorne to Announce Q1 2023 Financial Results and Hold Conference Call on May 15, 2023 BEVERLY, Mass. and TORONTO, May 08, 2023 (GLOBE NEWSWIRE) -- Hamilton Thorne Ltd. (TSX-V: HTL), a leading provider of precision instruments, consumables, software and services to the Assisted Reproductive Technologies (ART), research, and cell biology markets, today announced that it will release its financial results for the three months ended March 31, 2023 before market open on Monday, May 15, 2023. The press release, with accompanying financial information, will be posted on the Company’s we...
Hamilton Thorne to Participate in Bloom Burton & Co. Healthcare Invest...
Hamilton Thorne to Participate in Bloom Burton & Co. Healthcare Investor Conference on April 25-26, 2023 Company issues update on Equity Compensation Plan BEVERLY, Mass. and TORONTO, April 13, 2023 (GLOBE NEWSWIRE) -- Hamilton Thorne Ltd. (TSX-V: HTL), a leading provider of precision instruments, consumables, software and services to the Assisted Reproductive Technologies (ART), research, and cell biology markets, today announced that the Company will participate in the Bloom Burton & Co. Healthcare Investor Conference on April 25-26, 2023. David Wolf, President and CEO and Francesco F...
Hamilton Thorne Reports Record Revenue and EBITDA for the Quarter and ...
Hamilton Thorne Reports Record Revenue and EBITDA for the Quarter and Year Ended December 31, 2022 Revenue of $58.2 million for the year and $16.4 million for the 4th quarter; Adj. EBITDA of $10.1 million for the year and $3 million for the quarter BEVERLY, Mass. and TORONTO, March 30, 2023 (GLOBE NEWSWIRE) -- Hamilton Thorne Ltd. (TSX-V: HTL), a leading provider of precision instruments, consumables, software and services to the Assisted Reproductive Technologies (ART), research, and cell biology markets, today reported audited financial results for the fourth quarter and year-ended De...
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.